Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

Clinical trial NCT05483933 · COMPLETED

Trial details

NCT number: NCT05483933
Sponsor: Shattuck Labs, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Fallopian Tube Cancer Epithelial Ovarian Cancer Ovarian Cancer Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Primary Peritoneal Carcinoma

Start date: 2022-08-18
Primary completion: 2025-02-07
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.